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Background: Bacterial lower respiratory tract infections (bLRTIs) are com-
mon and potentially life threatening in cats and dogs. Antibiotic treatment
is often initiated before the diagnosis of bLRTI; therefore improved knowl-
edge of the aetiology and antibiotic susceptibility patterns of these infections
is essential to inform empiric antibiotic choices.
Methods: A retrospective study of microbiological, cytological results and
their drug susceptibilities from lower respiratory samples (n = 1989) pro-
cessed in a UK commercial laboratory between 2002 and 2012 was carried
out.
Results: Thirty-nine per cent of feline samples and 50% of canine sam-
ples were positive for bacterial growth with most yielding a single organ-
ism (72 % and 69%, respectively). Bordetella bronchiseptica (20.2% from dogs
and 2.3% from cats), Pasteurella spp. (23.2%, 31.8%), E. coli (16.2%, 13.6%)
and Pseudomonas spp. (11.1%, 11.4%) were most frequently isolated from
cytologically positive samples which contained intracellular bacteria (10%,
14%). Amoxycillin-clavulanate, cephalothin, cefovecin, oxytetracycline and
trimethoprim/sulfamethoxazole showed modest in vitro activity against E.
coli from dogs (approximately 70% susceptibility). Pseudomonas spp. were
resistant to enrofloxacin (50%), ticarcillin (25%) and marbofloxacin (13%) but
showed lower or zero resistance to aminoglycosides (approximately 7%) and
ciprofloxacin (0%). Multi drug resistance (acquired resistance to three or more
antimicrobial drug classes) was particularly common among E. coli isolates,
with 23% from feline samples and 43% from canine samples.
Conclusion: Resistance to certain first-choice antibiotics was detected in
bLRTIs highlighting the need for continued monitoring and sound evidence
to inform decision-making in the management of these infections.
1 INTRODUCTION
The correct identification of patients with lower res-
piratory tract (LRT) disease who will benefit from
antibiotics and the early administration of adequate
treatment are crucial to ensure successful clinical
outcomes and minimise the development of antibi-
otic resistance. This is complicated by the fact that
no combination of clinical, radiographic or gross
bronchoscopic findings can reliably confirm the
diagnosis of LRT infection or predict its aetiology.1
A definitive diagnosis is assumed when intracellular
bacteria are detected upon cytological examination
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of a lower respiratory sample and bacterial culture
yields a positive result.2,3 However, bacteria are only
demonstrable in a fraction of cytologic specimens
from animals with bacterial lower respiratory tract
infections (bLRTIs), and their absence does not rule
out bacterial infection.2,4,5 Furthermore, the inter-
pretation of bacterial culture results is hampered
by difficulties in differentiating true infection from
colonisation as the carina and large airways are not
sterile,5–8 The resident microflora includes oppor-
tunistic organisms that are often responsible for
bLRTIs in cats and dogs.4,6,7,9,10 Increased numbers of
bacteria can be found in patients with reduced airway
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clearance, a complication often associated with con-
ditions such as bronchitis, bronchiectasis and ciliary
dyskinesia.11,12
Antimicrobial susceptibility testing should always
be recommended to the client, although several fac-
tors can affect or delay this investigation. Certain
patients may be considered unstable and at greater
risk of obtaining a culture sample due to their res-
piratory disease, financial limitations may hinder
the diagnostic procedures required or there may be
clinical improvement on empirical treatment and
therefore continuation with the chosen antibiotics
without any diagnostic procedures.5,11,3 Furthermore,
the prolonged turnaround time for bacterial identifi-
cation and antibiotic susceptibility testing means that
microbiology results are not usually available to help
guide initial clinical decision-making regarding the
management of these patients. As a result, antibiotic
treatment is often initiated on an empirical basis
in animals with clinical evidence supportive of LRT
disease.
The use of antibiotics with poor or no in vitro activ-
ity against the pathogen(s) at the site of infection
and delays in the administration of adequate treat-
ment have been associated with higher morbidity
and mortality in cases of human counterparts that
are severely ill with bRTIs.13 Comprehensive antimi-
crobial protocols which guide decision-making for
empirical antibiotic therapy have been developed
for humans based on epidemiological data, and
they take into account the aforementioned patient
and antimicrobial factors.14 Guides to responsible
use of antibacterials have been produced in vet-
erinary medicine,15 but more elaborate protocols
based on epidemiological data such as those devel-
oped in humans would be very useful given the
high rates of empiric prescribing in small animal
practice.16,14
The aims of this study were to obtain data on the
aetiology and antibiotic resistance of bLRTIs from a
large cohort of canine and feline patients in the UK,
and to the author’s knowledge, few studies such as this
one have investigated bacterial species from samples
that include cytological evidence of respiratory dis-
ease.
2 MATERIALS AND METHODS
2.1 Data collection
Data from LRT samples from cats and dogs submit-
ted to NationWide Laboratories (NWL; Lancashire,
United Kingdom) for microbiological and cytologi-
cal examination between May 2002 and May 2012
were retrieved. The data included species, age and
gender of the patients, cytology reports and results
from bacterial culture and antibiotic susceptibility
testing. Samples from the same patient that had
the same organisms with identical antibiotic sus-
ceptibilities and were submitted within 3 months of
the original sample were excluded and those that
did not have identical antibiotic susceptibilities were
included in the analysis. Multidrug resistance (MDR)
was defined as acquired resistance to three or more
antimicrobial drug classes as proposed by Magiorakos
et al.17
Laboratory methods. Aerobic and anaerobic semi-
quantitative bacterial cultures of the LRT samples
were performed. A 10 μl loop was used to streak
each sample onto standard agar in four sectors
consecutively. The plates were incubated overnight
(18–24 h) at 37◦C and examined the following day.
The level of bacterial growth was reported as: no
growth; scanty (colonies limited to the initial sec-
tor); moderate (colonies on sectors 1–3); or profuse
(colonies on all 4 sectors). Microorganism identi-
fication was done by Gram-staining and standard
biochemical procedures. Antimicrobial susceptibility
testing was performed by the Kirby-Bauer method in
accordance with the Clinical and Laboratory Stan-
dards Institute (CLSI) and the results interpreted
based on contemporary criteria published by the same
organisation.18–20
2.2 Cytology
Direct smears of the fluid or direct and cytocen-
trifugated preparations of tracheal wash (TW) or
bronchoalveolar lavage (BAL) fluids were stained with
Wright-Giemsa stain and examined by clinical pathol-
ogists at NWL. Cytology reports recorded overall cel-
lularity, cell preservation, cell types, microorganisms
(if present) and interpretation of findings. The authors
classified the reports as acute neutrophilic, chronic-
active (mixed), chronic or eosinophilic inflammation,
haemorrhage or neoplasia. These classifications were
based on recommendations in veterinary cytologi-
cal textbooks and literature.8,21–26 The identification
of intracellular bacteria was considered diagnos-
tic of bacterial infection. Samples with evidence of
oropharyngeal contamination (squamous epithe-
lial cells, Simonsiella spp.) were excluded from the
study.
2.3 Data analysis
Results were expressed as mean ± standard deviation
(for age) and percentages. The frequency of different
bacterial species in LRT samples was calculated by
dividing the number of isolates from a certain species
by the total number of bacterial isolates obtained
from canine and feline samples. The two-sample
(unpaired) t-test was used to compare mean ages
at diagnosis between genders and animal species. A
p-value < 0.05 was considered significant. Statistical
analysis was performed using SPSS software (version
21, SPSS Inc., Chicago, USA).
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F I G U R E 1 Geographic distribution of veterinary practices by number of (a) canine samples and (b) feline samples
2.4 ETHICS STATEMENT
This work would be likely to gain approval in Europe
under the European Directive 2010/63/EU (on the
protection of animals used for scientific purposes) or
an appropriate clinical ethics committee.
3 RESULTS
3.1 Patient population, age and sex
of the patients
A total of 1989 consecutive non-repetitive lower air-
way samples from cats and dogs were submitted to
NWL for bacterial culture and susceptibility testing
during the 10-year period considered in our study.
Most of the samples were collected using a (TW) tech-
nique (n = 1630) and the remaining by BAL (n = 359).
The geographic distribution of the veterinary practices
from which the samples originated is shown in Fig-
ure 1, a large proportion of which were collected from
the West Midlands and Northwest UK. No information
was provided on the type of practice (first opinion vs.
referral), the samples were submitted from or any pre-
vious treatments administered to the patients. A con-
siderable proportion of the LRT samples belonged to
older patients aged nine or above (40% of cats and 36%
of dogs). Only a small percentage of samples belonged
to canine patients younger than 12 months (12%)
but this age group accounted for roughly 30% of the
cytology-positive samples. The mean age of patients
with cytologically-confirmed bacterial infection was
higher in cats than in dogs (7.8 vs. 5.1 years), with no
significant differences between genders (p < 0.05). No
considerable differences were observed between gen-
ders of both animal species in terms of proportion
of samples positive for bacterial growth or cytological
identification of intracellular bacteria.
3.2 Bacterial culture
Thirty-nine per cent (188/485) of feline samples and
50% (744/1504) of canine samples were positive for
bacterial growth, most yielded a single organism (72%
and 69%, respectively). Gram-negative species pre-
dominated with Pasteurella spp. (37% in cats and
20% dogs), Enterobacteriaceae (15%, 22%) and non-
fermenting Gram-negative bacilli (NF-GNB) (18%,
33%) accounting for the majority of isolates present
in the respiratory samples (Table 1). Bordetella bron-
chiseptica was the third most prevalent bacterial
species in samples from canine patients but only three
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T A B L E 1 Bacterial species isolated from LRT samples of cats and dogs
Dogs Cats
Bacterial species Total % TW % BAL % Cyto+ % Total % TW % BAL % Cyto+ %
α-haemolytic
Streptococcus
17 1.7 16 1.8 1 0.7 2 2.0 6 2.4 4 2.1 2 3.7 2 4.5
β-haemolytic
Streptococcus
29 2.8 25 2.9 4 2.7 6 6.1 12 4.8 10 5.2 2 3.7 2 4.5
S. aureus 11 1.1 11 1.3 0 0.0 0 0.0 2 0.8 2 1.0 0 0.0 1 2.3
S. pseudinter-
medius
43 4.2 36 4.1 7 4.8 4 4.0 5 2.0 5 2.6 0 0.0 0 0.0
Bordetella
bronchiseptica
157 15.4 138 15.8 19 13.0 20 20.2 3 1.2 2 1.0 1 1.9 1 2.3
Escherichia coli 164 16.1 147 16.9 17 11.6 16 16.2 30 12.1 26 13.4 4 7.4 6 13.6
Pasteurella spp 208 20.4 169 19.4 39 26.7 23 23.2 92 37.1 70 36.1 22 40.7 14 31.8
Pseudomonas
species
136 13.4 112 12.8 24 16.4 11 11.1 29 11.7 24 12.4 5 9.3 5 11.4
NF-GNB 333 32.7 283 32.5 50 34.2 34 34.3 45 18.1 36 18.6 9 16.7 9 20.5
Enterobacteriaceae 221 21.7 193 22.1 28 19.2 21 21.2 36 14.5 29 14.9 7 13.0 7 15.9
Anaerobes 12 1.2 10 1.1 2 1.4 2 2.0 19 7.7 14 7.2 5 9.3 5 11.4
Growth positive
samples
49.5 51.5 39.9 77.2 38.8 37.8 42.7 68.8
Samples 1 isolate 68.7 69.0 66.7 66.2 71.8 72.1 70.7 75.8
Samples > 2
isolates
31.3 31.0 33.3 33.8 28.2 27.9 29.3 24.2
Frequency of the different bacterial species in tracheal wash (TW), bronchoalveolar lavage (BAL), Cyto+ (cytology-positive) samples. Overall frequencies (inde-
pendent of the method used to collect the samples and the results from cytological examination) are also shown (Total).
isolates were found in feline samples. Anaerobic bac-
teria represented 7.7%19 of the isolates from cats, and
1.2%12 of the isolates from dogs and were often found
in combination with aerobic organisms (58% and 33%
of anaerobe-positive samples from cats and dogs).
Bacteroides spp., Clostridium spp. and Prevotella spp.
were the most frequently isolated anaerobic species.
The most common combinations of organisms in
cultures that yielded mixed bacterial growth were
Escherichia coli/Pasteurella spp. (n = 5 samples in
cats; n = 25 samples in dogs), E. coli/Pseudomonas
spp. (n = 2 in cats; n = 22 in dogs) and Pasteurella
spp./Pseudomonas spp. (n = 4 in cats; n = 9 in dogs).
3.3 Cytological examination
Cytology reports were available for 343 of 485 and
885 of 1504 samples from cats and dogs, respectively.
Intracellular bacteria were detected in 48 (14%) feline
samples and in 92 (10%) canine samples. Analysis of
culture results revealed that Pasteurella spp., Pseu-
domonas spp., E. coli, B. bronchiseptica (dogs) and
Streptococcus spp. (cats) were the bacterial species
most frequently isolated from cytology-positive sam-
ples (Table 1) which is in agreement with the overall
culture results described above. Approximately 25% of
the samples that had cytological evidence of bacterial
infection were culture negative. Intracellular bacteria
could not be detected in the majority of cytological
specimens from LRT samples that yielded bacterial
growth on culture (73% of samples from cats and 82%
of samples from dogs). The relative proportions of
the different bacterial species isolated from cytology-
positive samples seemed to be in accordance with
those isolated by BAL in both cats and dogs. Most
cytological specimens (with or without intracellular
bacteria) were classified as acute neutrophilic (24% of
cat samples and 36% of dog samples) or chronic-active
inflammation (28% and 28%, respectively).
3.4 Susceptibility to antibiotics
The resistance profiles of B. bronchiseptica (157 in
dogs), Pasteurella spp. (208 in dogs, 92 in cats), Pseu-
domonas spp. (136 in dogs) and E. coli (164 in dogs,
30 in cats) isolates (which represented approximately
65% of the isolates obtained in our study) are shown in
Tables 2–3.
Dogs: For most antibiotics, the levels of resis-
tance were low (<9% resistance) among Pas-
teurella spp. and B. bronchiseptica isolates (except
to ampicillin, trimethoprim/sulfamethoxazole and
cefovecin in the latter). Amoxycillin-clavulanate,
cephalothin, cefovecin, oxytetracycline and trimetho-
prim/sulfamethoxazole showed modest in vitro activ-
ity against E. coli and only fluoroquinolones retained
good activity against these isolates (>80% suscepti-
ble). Pseudomonas spp. were resistant to most of the
antibiotics tested, except aminoglycosides (approxi-
mately 90% susceptibility to gentamycin, tobramycin
and amikacin) and ticarcillin (approximate suscepti-
bility > 70%). Fluoroquinolones were the antibiotics
that showed better in vitro activity against the iso-
lates tested. The highest levels of resistance to this
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T A B L E 2 Antimicrobial resistance patterns of canine isolates. Only isolates with >30 data points have been included




of growth P AMP AMC CEF CEX CFX CVN OT CLI SXT ENR MAR CIP CN AK TOB TIC
Escherichia
(164)
Total – 56 26 26 – – 26 32 – 26 12 8 – – – – –
Pseudomonas
(136)
Total – – – – – – – – – – 50 13 0 8 5 6 25
Bordetella
(157)
Total – 47 1 1 – – 97 1 – 57 0 0 – – – – –
Pasteurella
(208)
Total – 9 0 0 – – 4 4 – 3 3 2 – – – – –
Abbreviations: AK, amikacin; AMP, ampicillin; AMC, amoxicillin-clavulanate; CEF, cephalothin; CEX, cephalexin; CFX, cefoxitin; CN, gentamicin; CIP,
ciprofloxacin, CLI, clindamycin; CVN-cefovecin; ENR-enrofloxacin; MAR-marbofloxacin; OT, oxytetracycline; P, penicillin, SXT, trimethoprim/sulfamethoxazole;
TOB, tobramycin; TIC, ticarcillin.
T A B L E 3 Antimicrobial resistance patterns of feline isolates. Only isolates with >30 data points have been included





growthP AMP AMC CEF CEX CFX CVN OT CLI SXT ENR MAR CIP CN AK TOB TIC
Escherichia30 Total – 47 23 23 – – 9 8 – – – – – – – – –
Pasteurella (92) Total – 9 0 0 – – 6 5 – 2 4 2 – – – – –
Abbreviations: AK, amikacin; AMP, ampicillin; AMC, amoxicillin-clavulanate; CEF, cephalothin; CEX, cephalexin; CFX, cefoxitin; CN, gentamicin; CIP,
ciprofloxacin, CLI, clindamycin; CVN-cefovecin; ENR-enrofloxacin; MAR-marbofloxacin; OT, oxytetracycline; P, penicillin, SXT, trimethoprim/sulfamethoxazole;
TOB, tobramycin; TIC, ticarcillin.
antibiotic class were observed in Pseudomonas spp.
The in vitro susceptibility of Pseudomonas spp. to
ciprofloxacin was 100%, while it was 87% to mar-
bofloxacin and 50% to enrofloxacin. MDR was partic-
ularly common among E. coli isolates (43%).
Cats (isolates > 30 samples): For most antibiotics,
the level of resistance was low among Pasteurella spp.
(<9% resistance). Resistance to ampicillin was con-
sidered high against E. coli isolates (approximately
50%) but cefovecin and doxycycline showed good
in vitro activity against these isolates (approximately
10% resistance each). Amoxicillin-clavulanate and
cefalothin retained good activity against Pasteurella
spp (100% susceptible) and moderate activity against
E. coli isolates (approximate susceptibility> 70%). 23%
of E. coli isolates were MDR.
4 DISCUSSION
Cats and dogs suspected of bLRTI often receive antibi-
otic treatment before the diagnosis is confirmed.
Overuse or inappropriate use of antibiotics, partic-
ularly in a veterinary hospital environment in the
USA, can lead to increased numbers of resistant bac-
teria being identified.27 In human medicine, initial
antibiotic choices can have a significant impact on
patient outcomes as inappropriate treatment, defined
as the use of antibiotic(s) to which the documented
pathogen is resistant, is associated with higher mor-
bidity and mortality.13 Another study found that
dogs suffering from pneumonia were often infected
with bacteria resistant to antibiotics administered for
4 weeks on an empirical basis; although this should
be interpreted with caution as confounding factors
such as acquired bacterial resistance and changing
bacterial populations should also be considered.16 An
up-to-date knowledge of the aetiology and antibiotic
resistance of bLRTIs is needed to improve the likeli-
hood of adequate empiric coverage.
The data reported here are largely in agreement
with previous reports on the aetiology of bLRTIs
in cats and dogs although with differences in the
frequency of the bacteria detected.1,2,5,16,28–31 Vari-
ations in these frequencies between the different
studies may reflect differences in study design. For
example the number of cases tested, difficulty dif-
ferentiating between primary infectious disease and
non-infectious respiratory disease, disparities in geo-
graphical location, timeframes of sampling and the
fact that some studies lacked information on previ-
ously administered antimicrobial treatment before
sampling.30 Furthermore, as our study was performed
over a 10-year period, it is possible that results from
parts of this period as well as results performed after
the completion of this study may vary.
In our study, the majority of samples that yielded
bacterial growth isolated a single pathogen (71.8%
from cats and 68.7% from dogs). Pasteurella spp., E.
coli, Pseudomonas spp. and B. bronchiseptica (the lat-
ter only in dogs) were the bacterial species most com-
monly implicated, accounting for 65% of isolates. A
recent study in the USA has highlighted the poten-
tial of dysbiosis as associated with canine pneumonia
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while acknowledging the importance of overgrowth by
a single dominant phylotype.32
Cytology positive samples were found to be very low
in our study (14% in cats and 10% in dogs) compared
to culture positive samples (39% and 50%, respec-
tively), and intracellular bacteria were not detected in
the majority of cytological specimens that were culture
positive (73% and 82%, respectively). A recent study
examining TW cytology results from dogs with respi-
ratory disease revealed similar results of discordancy
with a high number of cytology negative and culture
positive results (55.4%).33 Pre-treatment with antibi-
otics may affect cytology results and as no informa-
tion was provided on the administration of medication
to patients before sample collection in our study, this
influential factor cannot be excluded.2,33 In addition,
culture of commensal organisms in animals with non-
infectious respiratory disease may have also affected
these results or even bacteria that are difficult to cul-
ture but still detectable on cytology. One example of
this is Mycoplasma spp. which are hard to culture but
can act as primary pathogens in respiratory infections
in cats and dogs.33,34
Broad-spectrum coverage is recommended for
patients suspected of bacterial pneumonia due to the
multiplicity of agents that can be involved.1,2,5,11,16,35
From our laboratory results, amoxicillin–clavulanate
showed excellent in vitro activity against B. bron-
chiseptica and Pasteurella spp., but the levels of
susceptibility were however lower in isolates of other
bacterial species. For example, over 20% of E. coli
were classified as resistant which is in agreement with
similar studies.2,28,30,31 Nevertheless, good to moder-
ate in vitro activity of amoxicillin–clavulanate against
respiratory pathogens (except Pseudomonas spp.) was
reported in previous studies.2,5,30,31
Fluoroquinolones were the antibiotics that showed
better in vitro activity against the isolates tested
as shown by a similar retrospective study of med-
ical records between 1989 and 2011 in Germany.30
This could be due to their minimal use in vet-
erinary medicine; possibly attributed to successful
responsible antibiotic use messaging and education.
The highest levels of resistance to this antibiotic
class were observed in Pseudomonas spp., particu-
larly those obtained from canine samples. The in vitro
susceptibility of Pseudomonas spp. to ciprofloxacin
(100%) was significantly higher than enrofloxacin
(50%) and slightly superior to marbofloxacin (87%),
this susceptibility trend to fluoroquinolones was sim-
ilar for all isolates. The majority of enrofloxacin
and/or marbofloxacin-resistant Pseudomonas isolates
(>90%) detected were susceptible to aminoglycosides
(gentamicin, amikacin and/or tobramycin) and ticar-
cillin. As with humans, antipseudomonal coverage
should be considered in the treatment of patients
with risk factors for P. aeruginosa infection such as
pulmonary comorbidities,36 fluoroquinolones such as
ciprofloxacin are one of the options as they penetrate
well into the respiratory tract.4 In this study we used
breakpoints that were the standard of practice at the
time of the study (CLSI 2008). Since then new guide-
lines (CLSI 2018) have developed with changes in cer-
tain breakpoints such as those for ciprofloxacin which
would present differences in perceived antibiotic sus-
ceptibilities.
According to this and previous reports, anaer-
obes can be isolated from 1%–48% of bLRTI cases,
either as a single agent or as part of a polymicrobial
infection.2,28,37 Their role in bacterial pneumonia is
not wholly understood, but it is prudent to provide
anaerobic coverage in the empirical treatment of these
infections. The spectrum of activity of amoxicillin–
clavulanate encompasses most of the species of
anaerobic bacteria that have been implicated in bLR-
TIs in cats and dogs. Enrofloxacin, on the other hand,
is not active against obligate anaerobes but its spec-
trum can be broadened, for example, by the addition
of a penicillin, clindamycin or metronidazole. Metron-
idazole monotherapy is, however, not recommended
due its lack of activity against aerobic bacteria. Amox-
icillin (non-potentiated) is also not recommended
for the empiric use against respiratory bacterial
infections given its limited spectrum and observed
resistance levels against the most common respiratory
pathogens, as previously reported.30
The value of antimicrobial treatment in uncom-
plicated cases of canine infectious respiratory dis-
ease (CIRD) is thought to be limited.38 It is indi-
cated if deeper respiratory or systemic bacterial
infection develops, particularly if fever, lethargy
or inappetence is present alongside mucopurulent
discharges.11,38 Doxycycline is regarded as a first-line
antibiotic for the treatment of infections caused by
B. bronchiseptica,39,11 the primary bacterial cause of
CIRD.38,40 Resistance to this drug has been identi-
fied in other settings in the USA (1989–1995, 2001)
and Germany (2010–2012);28,41,42 however the great
majority (99.3%) of B. bronchiseptica isolates included
in our study were susceptible to doxycycline. Unfor-
tunately, Steinfeld et al have indicated that only a
low proportion of other Gram-negative bacteria were
susceptible to doxycycline, and a moderate propor-
tion of Staphylococcus spp. Although B. bronchisep-
tica seems to be highly susceptible to this drug in
vitro, some cases may be refractory and doxycycline
may not be recommended for the empirical treatment
of other bLRTIs.43,30,31,44 Based on our susceptibility
data, amoxicillin–clavulanate is also a good choice for
the treatment of B. bronchiseptica infections, which is
in agreement with previous reports.28,41
Studies in humans show that the validity of bacterial
culture in the diagnosis of bLRTIs can be significantly
affected by just a few hours of effective treatment
suggesting that the collection of airway samples for
microbiological investigation should precede the initi-
ation of empirical antibiotics.45,46 Furthermore, prior
antibiotic therapy was associated with false-negative
rates of 10%–40% in human patients with bacterial
pneumonia,47 and several strategies have been pro-
posed to increase diagnostic accuracy in such cases,
including lowering the threshold for clinically sig-
nificant growth or stopping antibiotic treatment.46,48
Waiting for the inhibitory effects of the antibiotics to
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’wash off’ can pose undue risks to the patients. In pre-
vious reports (USA, 2000–2008) concurrent antibiotic
use did not seem to interfere with culture results5,37
as the pathogens were likely to have been refractory
to the antibiotics administered. The optimal strategy
for the collection of respiratory specimens when the
patient is receiving antibiotics is yet to be defined,
as are the thresholds for clinically significant bacte-
rial growth. Therefore, microbiological results should
always be interpreted with caution and in conjunction
with other clinical and laboratory findings.
In this study the majority (82%) of samples pro-
cessed at NWL were collected by TW, either performed
blindly or with the aid of a bronchoscope/endoscope.
Surprisingly, there was a higher number of Pseu-
domonas isolates in TW samples than BAL samples
even though Pseudomonas is frequently found to
contaminate endoscopes.49 Veterinary laboratories
usually perform semi-quantitative cultures of LRT
samples therefore the most common clinical practice
seems to be the semi-quantitative analysis of TW spec-
imens. Furthermore, the lower airways in healthy dogs
and cats are not considered sterile and the passage
of an endoscope during BAL sampling can introduce
oropharyngeal contamination.32,50 This highlights
the importance of cytology in the evaluation of these
patients.
This study used methods that were the standard
of practice at the time of the study (2012) including
CLSI breakpoints (CLSI 2008) and identification meth-
ods. New and improved standards have since been
developed (CLSI 2018) which may have presented
differences in the antibiotic susceptibility results. In
addition, as the analysis of the study was based on lab-
oratory submissions, there was no clinical information
such as previous antibiotic treatments, symptoms,
type of practice the samples were submitted from
(first opinion or referral) or other factors that may
have influenced the evaluation of the results.
5 CONCLUSION
The results from our study provide evidence on the
aetiology and antibiotic susceptibility patterns of bLR-
TIs to antibiotics commonly used in their treatment
in cats and dogs. These results reflect the complex
nature of such infections and the existence of several
unsettled controversies in their diagnosis and treat-
ment which highlights the importance of performing
cytology and antimicrobial susceptibility testing when
possible. Continued monitoring of the susceptibility
profiles of bLRTIs is necessary to guide empirical
treatment protocols as well as maintain antimicro-
bial efficacy and aid combat antibiotic resistance in
veterinary and human medicine.
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